This protection against CRC has been associated to NF-kB repression by these probiotic bacteria (Roller et al., 2004a; Kim et al., 2010; Celiberto et al., 2017; Paveljšek et al., 2018). The gene discussed is NFKB1; the disease is colorectal carcinoma.